Danaher Co. (NYSE:DHR) Position Trimmed by First Western Trust Bank

by · The Cerbat Gem

First Western Trust Bank trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 6.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 23,454 shares of the conglomerate’s stock after selling 1,649 shares during the period. First Western Trust Bank’s holdings in Danaher were worth $5,384,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. Broderick Brian C lifted its holdings in shares of Danaher by 4.6% during the fourth quarter. Broderick Brian C now owns 65,289 shares of the conglomerate’s stock worth $14,987,000 after buying an additional 2,879 shares during the last quarter. ExodusPoint Capital Management LP bought a new stake in Danaher during the 4th quarter worth about $5,193,000. Arete Wealth Advisors LLC boosted its position in shares of Danaher by 23.9% in the 4th quarter. Arete Wealth Advisors LLC now owns 4,681 shares of the conglomerate’s stock worth $1,074,000 after purchasing an additional 903 shares during the last quarter. World Investment Advisors increased its stake in Danaher by 7.8% in the fourth quarter. World Investment Advisors now owns 13,956 shares of the conglomerate’s stock valued at $3,204,000 after purchasing an additional 1,008 shares in the last quarter. Finally, Biltmore Family Office LLC raised its position in shares of Danaher by 10.1% during the fourth quarter. Biltmore Family Office LLC now owns 1,901 shares of the conglomerate’s stock worth $437,000 after purchasing an additional 174 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is owned by company insiders.

Danaher Stock Down 3.6 %

Shares of DHR opened at $197.75 on Friday. Danaher Co. has a 52-week low of $194.02 and a 52-week high of $281.70. The company has a market cap of $141.33 billion, a PE ratio of 37.45, a P/E/G ratio of 2.66 and a beta of 0.86. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The business has a fifty day moving average of $211.28 and a 200 day moving average of $234.92.

Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the business earned $2.09 EPS. On average, sell-side analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher’s dividend payout ratio is 24.24%.

Analyst Ratings Changes

A number of research firms recently weighed in on DHR. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research report on Friday, December 13th. Scotiabank started coverage on Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective on the stock. Robert W. Baird cut their price target on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Jefferies Financial Group reduced their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Finally, The Goldman Sachs Group raised Danaher from a “neutral” rating to a “buy” rating and set a $260.00 target price for the company in a report on Friday, March 21st. Five research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. Based on data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $278.24.

Read Our Latest Stock Report on Danaher

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).